Status:

COMPLETED

Intravenous Versus Intracoronary Use of Abciximab

Lead Sponsor:

University Hospital, Gentofte, Copenhagen

Conditions:

Atherosclerosis

Ischemic Heart Disease

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

The aim of this study is to investigate wether intracoronary use of bolus Abciximab is superior to intravenous bolus in patients undergoing percutaneous coronary intervention.

Detailed Description

STEMI patients with indication for adjuvant therapy with GPI during pPCI, and who gave informed consent, were randomized, using sealed, opaque envelopes, to either IC or IV bolus (0.25 mg/kg body weig...

Eligibility Criteria

Inclusion

  • Usually inclusion criteria for Abciximab, that is:
  • Adjunct to PCI for the prevention of cardiac ischemic complications:
  • In patients undergoing PCI
  • In patients with UA not responding to conventional medical therapy when PCI is planned within 24 hours

Exclusion

  • Usually exclusion criteria for Abciximab, that is:
  • Active internal bleeding, recent (within 6 weeks) gastrointestinal (GI) or genitourinary (GU) bleeding of clinical significance
  • History of cerebrovascular accident (CVA) within 2 years, or CVA with a significant residual neurological deficit
  • Bleeding diathesis
  • Administration of oral anticoagulants within 7 days unless prothrombin time is less than or equal to 1.2 times control, thrombocytopenia (\<100,000 cells/µL)
  • Recent (within 6 weeks) major surgery or trauma
  • Intracranial neoplasm
  • Arteriovenous malformation, or aneurysm
  • Severe uncontrolled hypertension
  • Presumed or documented history of vasculitis
  • Use of intravenous dextran before percutaneous coronary intervention, or intent to use it during intervention
  • Known hypersensitivity to any component of this product or to murine proteins.

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

355 Patients enrolled

Trial Details

Trial ID

NCT00685464

Start Date

January 1 2006

End Date

December 1 2009

Last Update

August 10 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept. of Cardiology, Gentofte University Hospital

Hellerup, Denmark, 2900